A Non-Profit Works to Advance a DMD Gene Therapy
RARECast - Un pódcast de RARECast - Jueves
Categorías:
Frederic Revah, CEO of Genethon, discusses Duchenne muscular dystrophy, the organization’s efforts to complete clinical development of its gene therapy for the condition, and how it might commercialize the treatment.
